Literature DB >> 10410257

Diagnostic approach in a patient presenting with polymyalgia.

M A Gonzalez-Gay, C Garcia-Porrua, C Salvarani, G G Hunder.   

Abstract

Entities:  

Mesh:

Year:  1999        PMID: 10410257

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


× No keyword cloud information.
  7 in total

1.  Cerivastatin-induced polymyalgia rheumatica-like illness.

Authors:  Vincent Goëb; Nathalie Guillemant; Olivier Vittecoq; Xavier Le Loët
Journal:  Clin Rheumatol       Date:  2004-01-24       Impact factor: 2.980

2.  Clinical guidelines: Best practices and uncertainties in the management of PMR.

Authors:  Miguel A González-Gay; Javier Llorca
Journal:  Nat Rev Rheumatol       Date:  2015-10-20       Impact factor: 20.543

Review 3.  Giant cell arteritis and polymyalgia rheumatica: pathophysiology and management.

Authors:  Miguel A Gonzalez-Gay; Carlos Garcia-Porrua; Jose A Miranda-Filloy; Javier Martin
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

4.  Increased 67gallium uptake among polymyalgia rheumatica patients. Is it additional evidence of its vasculitic nature?

Authors:  T Reitblat; C L Ben-Horin; A Reitblat
Journal:  Rheumatol Int       Date:  2006-04-05       Impact factor: 2.631

Review 5.  Elderly onset rheumatoid arthritis: differential diagnosis and choice of first-line and subsequent therapy.

Authors:  Juan Ignacio Villa-Blanco; Jaime Calvo-Alén
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

Review 6.  Genetic epidemiology. Giant cell arteritis and polymyalgia rheumatica.

Authors:  M A Gonzalez-Gay
Journal:  Arthritis Res       Date:  2001-02-26

7.  Late onset undifferentiated spondyloarthritis presenting with polymyalgia rheumatica features: description of seven cases.

Authors:  Ignazio Olivieri; Carlos Garcia-Porrua; Angela Padula; Fabrizio Cantini; Carlo Salvarani; Miguel A Gonzalez-Gay
Journal:  Rheumatol Int       Date:  2007-04-11       Impact factor: 3.580

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.